| # | Drug | Count |
|---|---|---|
| 0 | NITRIC OXIDE | 12 |
| 1 | SILDENAFIL | 8 |
| 2 | SILDENAFIL CITRATE | 8 |
| 3 | SILDENAFIL POWDER, | 8 |
| 4 | METFORMIN | 7 |
| 5 | METFORMIN ER 500 MG | 7 |
| 6 | METFORMIN ER 750 MG | 7 |
| 7 | METFORMIN HYDROCHLORIDE | 4 |
| 8 | TERIFLUNOMIDE | 4 |
| 9 | 0XYGEN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITRIC OXIDE | 12 | 0.0026 |
| 1 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 2 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 3 | DOPAMINE HYDROCHLORIDE | 1 | 0.0003 |
| 4 | DOBUTAMINE | 1 | 0.0003 |
| 5 | SILDENAFIL POWDER, | 8 | 0.0002 |
| 6 | LABETALOL | 3 | 0.0002 |
| 7 | EPOPROSTENOL | 2 | 0.0002 |
| 8 | TRANEXAMIC ACID | 1 | 0.0001 |
| 9 | TERIFLUNOMIDE | 4 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vasodilator [EPC] | 12 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 9 |
| 2 | Prostacycline Vasodilator [EPC] | 5 |
| 3 | Pyrimidine Synthesis Inhibitor [EPC] | 4 |
| 4 | Atypical Antipsychotic [EPC] | 3 |
| 5 | Corticosteroid [EPC] | 3 |
| 6 | beta-Adrenergic Blocker [EPC] | 3 |
| 7 | Cardiac Glycoside [EPC] | 2 |
| 8 | Aldosterone Antagonist [EPC] | 1 |
| 9 | Antifibrinolytic Agent [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 1 | Pyrimidine Synthesis Inhibitor [EPC] | 4 | 0.0001 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 9 | 0.0001 |
| 3 | Prostacycline Vasodilator [EPC] | 5 | 0.0000 |
| 4 | Cardiac Glycoside [EPC] | 2 | 0.0000 |
| 5 | Catecholamine [EPC] | 1 | 0.0000 |
| 6 | beta-Adrenergic Blocker [EPC] | 3 | 0.0000 |
| 7 | Atypical Antipsychotic [EPC] | 3 | 0.0000 |
| 8 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 9 | Endothelin Receptor Antagonist [EPC] | 1 | 0.0000 |